Symbiant

What Symbiant does

Symbiant is a Dutch clinical pathology laboratory organized as a joint venture (besloten vennootschap) of three North Holland hospitals — Noordwest Ziekenhuisgroep, Dijklander Ziekenhuis, and Zaans Medisch Centrum — founded in 2011 to consolidate regional pathology operations. The company provides comprehensive diagnostic pathology services including clinical pathology (histology and cytology), molecular diagnostics (next-generation sequencing, MLPA, PCR, in situ hybridization, microsatellite instability analysis, immunohistochemistry), and rapid diagnostic services for breast and lung cancer care pathways. With approximately 150 employees including 18 pathologists across three locations (Alkmaar, Hoorn, Zaandam), Symbiant processes roughly 90,000 diagnoses annually and holds ISO 15189 accreditation (Registration M277).

The company is one of three designated national laboratories for the Dutch cervical cancer screening program (BVO-BMHK), processing approximately one-third of all Dutch self-sampling tests, and handles colorectal cancer screening (BVO-DK) tissue samples for regional hospitals. Its customers include the three founding hospital shareholders, general practitioners and independent treatment centers (ZBC's) across North Holland, the national screening program, and external scientific researchers requesting tissue materials through the PALGA portal. Revenue is generated primarily through Dutch healthcare system reimbursement for diagnostic services, supplemented by standardized research material fees (e.g., €20 admin, €7.50 per original section) and medical education/training programs delivered in partnership with Amsterdam UMC and Hogeschool Leiden.

Symbiant operates a fully digital pathology workflow and offers subspecialty expertise through multidisciplinary team discussions and organ-specific panels. The lab runs training programs including the B-opleiding pathology residency and a pathologist's assistant program. Strategic referral partnerships with Amsterdam UMC, UMC Utrecht, and LUMC extend its subspecialty reach. Distribution occurs through direct institutional relationships, courier-based sample collection (Starlet, DCWF, AMP), the national PALGA registry, and the Bevolkingsonderzoek Nederland screening program.

Name

Symbiant

Legal name

Symbiant BV

Website

https://symbiant.nl

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

101–250 employees

Short description

Symbiant is a Dutch clinical pathology laboratory (BV), founded in 2011 as a joint venture of three North Holland hospitals, providing diagnostic histology, cytology, molecular diagnostics, and screening pathology services to hospitals, GPs, and the Dutch national cancer screening program.

Ownership category

akta.pro rank

Product category

Clinical Pathology Diagnostics

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)

Keywords

• Clinical pathology diagnostics
• Molecular diagnostic services
• Histopathology laboratory
• Cancer screening programs
• Pathology residency training

Headquarters

HQ city

Alkmaar

HQ country

Netherlands

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Pathology Diagnostic Services: Core revenue from providing clinical pathology diagnostic services to hospitals, general practitioners, ZBC's, and population screening programs. Services include histological and cytological diagnosis, molecular diagnostics, and rapid diagnostics. Revenue is generated through healthcare system reimbursement mechanisms.
2. Population Screening (BVO): Participation in national cancer screening programs including cervical cancer (BVO-BMHK) and colorectal cancer (BVO-DK). Processes approximately one-third of all Dutch cervical cancer screening tests from self-sampling kits.
3. Research Material Services: Provides tissue materials to external scientific researchers for a fee. Charges administrative costs, fees for original sections, blank slides, extra HE sections, and tissue blocks for additional testing.
4. Medical Education and Training: Provides B-opleiding (residency training) to pathologists in collaboration with Amsterdam UMC. Offers clinical rotations and educational programs for medical students and specialists.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Core offering

Symbiant is a pathology laboratory providing clinical pathology diagnostics (histology and cytology), molecular diagnostics (NGS, MLPA, PCR, in situ hybridization), national population cancer screening (cervical and colorectal), and rapid diagnostics for cancer care pathways. Services are delivered to hospitals, general practitioners, and independent treatment centers across North Holland from three integrated locations, processing approximately 90,000 diagnoses annually under an ISO 15189 accredited quality system.

Product overview

Symbiant is a pathology laboratory offering a comprehensive suite of diagnostic services operating as a unified pathology center with multiple interconnected service lines. The core offerings include clinical pathology (histology and cytology), molecular diagnostics (NGS, MLPA, PCR, in situ hybridization), population screening programs (cervical and colorectal cancer), rapid diagnostics for cancer care pathways, and specialized expert consultation. Supporting services include research and development, external consultancy, autopsy services, Mohs surgery assistance, and professional training programs for pathologists and pathology assistants. The laboratory is structured around three locations (Alkmaar, Hoorn, Zaandam) serving hospitals in North Holland, with approximately 150 employees processing around 90,000 diagnoses annually.

Differentiator

Problem solved

Functional benefit

Products and services

• Moleculaire diagnostiek (Molecular Diagnostics) Detection of abnormalities at DNA and RNA level using molecular techniques including Next Generation Sequencing (NGS), MLPA, microsatellite instability analysis, in situ hybridization, and PCR for cancer diagnosis and personalized medicine treatment planning.

Quantifiable outcome

• 90,000 diagnoses per year
• +2 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature8 records

Partnerships

13 partnerships are on record, tiered core, major, secondary and minor.

• Noordwest Ziekenhuisgroep (NWZ)coreStrategic or Co-development Partner · 1 January 2011Founding partner and shareholder of Symbiant BV. Formerly known as Medisch Centrum Alkmaar. Provides pathology diagnostic services at Alkmaar location. The hospital's pathology department is integrated into Symbiant's operations.
• Dijklander ZiekenhuiscoreStrategic or Co-development Partner · 1 January 2011Founding partner and shareholder of Symbiant BV. Formerly known as Westfriesgasthuis. Provides pathology diagnostic services at Hoorn location. The hospital's pathology department is integrated into Symbiant's operations.
• Zaans Medisch Centrum (ZMC)coreStrategic or Co-development Partner · 1 January 2011Founding partner and shareholder of Symbiant BV. Provides pathology diagnostic services at Zaandam front office location. The hospital's pathology services are integrated into Symbiant's operations.
• Amsterdam UMCmajorStrategic or Co-development PartnerAcademic medical center collaboration for B-opleiding (pathology residency training). Also collaborates for sarcoma diagnostics where molecular techniques not available at Symbiant are outsourced.
• UMC UtrechtsecondaryStrategic or Co-development PartnerReferral partner for specialized molecular techniques not available at Symbiant, particularly for brain tumor diagnostics where the organization lacks laboratory equipment.
• Leiden University Medical Center (LUMC)secondaryStrategic or Co-development PartnerReferral partner for specialized molecular techniques not available at Symbiant, particularly for bone tumor diagnostics.
• Hogeschool LeidenmajorStrategic or Co-development PartnerEducational partnership for pathologist's assistant training program (pathologists' assistant opleiding). Symbiant developed this post-HLO education program and provides instruction in collaboration with the university of applied sciences.
• PALGA (Pathologisch Anatomisch Landelijk Geautomatiseerd Archief)majorTechnology or IntegrationNational pathology registry system. Symbiant uses the PALGA portal for researchers to request materials. Patient privacy and GDPR compliance is managed through PALGA protocols.
• StarletsecondaryChannel Partner/ Reseller/ DistributorMaterial ordering service for general practitioners in Alkmaar region. Courier delivers sampling materials to GP practices.
• DCWF (Dutch Courier Service for Medical Transport)secondaryChannel Partner/ Reseller/ DistributorCourier service for general practitioners in Hoorn region. The courier takes sampling materials when visiting GP practices.
• AMP (Medische Logistiek)secondaryChannel Partner/ Reseller/ DistributorMedical logistics courier service for general practitioners in Zaandam region. The courier takes sampling materials when visiting GP practices.
• OOR Amsterdam UMCmajorStrategic or Co-development PartnerTraining network for pathology residents (aios). Symbiant provides peripheral clinical pathology rotations for residents from Amsterdam UMC through the OOR (Opleidingsregistratie en Opleidingscontinuïteit Regio) Amsterdam.
• Uitvaartverzorging DuinminorOthersFuneral services provider that transports deceased patients for autopsies at no cost to next of kin within the entire region.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Cerba Healthcare: European clinical diagnostics and specialty pathology provider with reference laboratory capabilities analogous to Symbiant's central laboratory role within North Holland.
• SYNLAB: Pan-European medical diagnostics provider with extensive pathology and molecular testing operations, an incumbent competitor for any expansion beyond the North Holland catchment.
• Eurofins Genoma / Eurofins Clinical Diagnostics: Global diagnostics group with broad molecular and genetic testing capabilities, comparable as a benchmark for scale and price competition in specialized molecular diagnostics.
• Unilabs: Large European diagnostics network offering pathology, molecular diagnostics and screening services across multiple countries — a broad incumbent whose portfolio overlaps Symbiant's offering at much larger scale.

Direct peers

• Stichting Laboratorium Pathologie Velsen / LabPON: Regional Dutch pathology laboratory combining hospital pathology operations across multiple sites, with screening program participation and molecular diagnostics — closely mirroring Symbiant's JV structure and service mix.
• Jeroen Bosch Ziekenhuis Laboratorium Pathologie: Hospital-anchored Dutch pathology department offering clinical pathology, cytology and molecular diagnostics within a single regional hospital network, comparable in scope to one of Symbiant's sites.
• Pathologie Friesland: Regional Dutch pathology laboratory providing clinical pathology, molecular diagnostics and screening services across Friesland, structurally analogous to Symbiant's regional laboratory model in North Holland.

Others

• Pathologie-DNA (Stichting PALGA): National Dutch pathology registry and tissue request portal; Symbiant uses PALGA for researcher material requests. Listed as an enabling ecosystem participant rather than a direct competitor.

Regional players

• Amsterdam UMC Pathology (Amsterdam UMC): Academic pathology department that receives referrals from Symbiant (e.g., sarcoma diagnostics) and partners on B-opleiding training, operating in the same Dutch geography at higher-acuity complexity.
• UMC Utrecht Pathology: Academic pathology department to which Symbiant refers complex molecular cases (notably brain tumors), serving as both a referral partner and an adjacent competitor in the Dutch market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/symbiantpathologie

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Symbiant